Menu
Home
About
About Us
Our Team
Publications
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Manufacturer
Investors
Contact Us
Shareholder Benefits
Make An Appointment
CXCR1 expression to improve anti-cancer efficacy of intravenously injected CAR-NK cells in mice with peritoneal xenografts
«
Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts
B2 miceta-roglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytes
»